Apolipoprotein A-V genetic variation and plasma lipoprotein response to fibrates.
Hegele
Robert A
RA
Pollex
Rebecca L
RL
D000072040:Apolipoprotein A-V; D001054:Apolipoproteins A / Q000235:genetics*; D011345:Fenofibrate / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D050356:Lipid Metabolism / Q000187:drug effects; D008074:Lipoproteins / Q000097:blood*; D020641:Polymorphism, Single Nucleotide; D019518:Postprandial Period; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood*
C437704:APOA5 protein, human; D000072040:Apolipoprotein A-V; D001054:Apolipoproteins A; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D014280:Triglycerides; D011345:Fenofibrate